Relmada Therapeutics
RLMD
#9904
Rank
NZ$20.28 M
Marketcap
$0.67
Share price
4.60%
Change (1 day)
-87.10%
Change (1 year)

Market capitalization of Relmada Therapeutics (RLMD)

Market cap: NZ$20.28 Million

As of December 2024 Relmada Therapeutics has a market cap of NZ$20.28 Million. This makes Relmada Therapeutics the world's 9904th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Relmada Therapeutics from 2014 to 2024

End of year Market Cap

Year Marketcap Change
2024NZ$20.28 M-89.71%
2023NZ$0.19 B19.09%
2022NZ$0.16 B-81.92%
2021NZ$0.91 B26.04%
2020NZ$0.72 B-13.29%
2019NZ$0.83 B1540.6%
2018NZ$51.02 M285.22%
2017NZ$13.24 M-30.05%
2016NZ$18.93 M-56.79%
2015NZ$43.82 M-79.36%
2014NZ$0.21 B

End of Day market cap according to different sources

On Dec 23rd, 2024 the market cap of Relmada Therapeutics was reported to be:

NZ$20.28 Million
by Nasdaq info icon info icon
NZ$20.28 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
NZ$2.85 B 13,999.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
NZ$10.22 B 50,334.10%๐Ÿ‡บ๐Ÿ‡ธ USA